Tema Oncology ETF (CANC) Chart & Stock Price History $25.91 +0.38 (+1.49%) As of 01/30/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Oncology ETF Stock Price Performance 5 Day Performance+1.61%1 Month Performance+6.85%3 Month Performance-7.10%6 Month Performance-11.66%Year-To-Date Performance+6.58%1 Year Performance-1.82% Receive CANC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address CANC Stock Chart for Friday, January, 31, 2025 CANC Chart by TradingView Tema Oncology ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/29/2025$25.58$25.53-0.20%$25.68$25.4615,079 shs$62.04 million01/28/2025$25.63$25.58-0.20%$25.76$25.3723,760 shs$62.16 million01/27/2025$25.50$25.63+0.51%$25.88$25.5013,711 shs$61.51 million01/24/2025$25.65$25.50-0.58%$25.72$25.4323,133 shs$61.20 million01/23/2025$25.23$25.65+1.66%$25.68$25.0413,682 shs$60.28 million01/22/2025$25.16$25.23+0.28%$25.35$25.1119,121 shs$59.29 million01/21/2025$24.46$25.16+2.86%$25.18$24.7618,320 shs$59.13 million01/20/2025$24.46$24.46$24.67$24.4627,892 shs$57.48 million01/17/2025$24.49$24.46-0.12%$24.67$24.4627,892 shs$52.83 million01/16/2025$24.54$24.49-0.20%$24.62$24.3723,031 shs$52.90 million Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 01/15/2025$24.28$24.54+1.07%$24.82$24.40101,096 shs$53.01 million01/14/2025$24.62$24.28-1.38%$24.85$24.2121,736 shs$48.80 million01/13/2025$24.48$24.62+0.57%$24.66$23.9717,292 shs$49.49 million01/10/2025$24.94$24.48-1.84%$25.32$24.29134,466 shs$47.25 million01/09/2025$24.94$24.94$25.24$24.8352,070 shs$48.13 million01/08/2025$25.16$24.94-0.87%$25.24$24.8352,070 shs$48.13 million01/07/2025$24.82$25.16+1.37%$25.48$24.98126,715 shs$48.56 million01/06/2025$24.72$24.82+0.40%$25.37$24.7419,092 shs$47.90 million01/03/2025$24.44$24.72+1.15%$25.31$24.3514,584 shs$47.71 million01/02/2025$24.31$24.44+0.53%$24.70$24.3322,972 shs$42.53 million01/01/2025$24.31$24.31$24.55$24.2219,304 shs$42.30 million12/31/2024$24.25$24.31+0.25%$24.55$24.2219,304 shs$42.30 million12/30/2024$24.67$24.25-1.70%$24.55$24.1119,420 shs$42.20 million Related Companies VPN Stock Price Chart TARK Stock Price Chart FDCF Stock Price Chart AGNG Stock Price Chart SPC Stock Price Chart BLCN Stock Price Chart UFO Stock Price Chart FMED Stock Price Chart SARK Stock Price Chart HRTS Stock Price Chart Receive CANC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CANC) was last updated on 1/31/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThe #1 Stock for Trump’s Second Term?Imagine how much money you could make if you bought all of the top performing stocks during Trump's second ter...InvestorPlace | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
